[The content of basic apoproteins A1 and B and lipids in the blood serum of women with type-I and -II diabetes mellitus and ischemic heart disease]. / Soderzhanie osnovnykh apobelkov A1 iB i lipidov v syvorotke krovi u zhenshchin s I i II tipami sakharnogo diabeta i ishemicheskoi bolezn'iu serdtsa.

The paper is concerned with quantitative characterization of lipoprotein (LP) spectrum, including the determination of the content of apoproteins A1 and B, in 69 women aged 40 to 59 with normal body mass, suffering from types I and II diabetes mellitus in the state of compensation of carbohydrate metabolism, with CHD and without signs of it, using a method of quantitative rocket immunoelectrophoresis. Atherogenic dyslipoproteinemia was observed in the presence of CHD in women with types I and II diabetes mellitus. In patients without clinical signs of CHD (in type I diabetes mellitus) serum atherogenic shifts were absent whereas in type II in spite of the absence of clinical signs of CHD disorders in the content and cholesterol transport function of HDLP particles were found.

[Quantitative characterization of the main lipid and apoprotein components of plasma lipoproteins in men with types I and II diabetes mellitus with and without coronary heart disease]. / Kolichestvennaia kharakteristika osnovnykh lipidnykh i apobelkovykh komponentov lipoproteinov plazmy u muzhchin, stradauyshchikh sakharnym diabetom I and II tipov, s ishemicheskoi bolezn'iu serdtsa i bez nee.

The paper is devoted to the characterization of the spectrum of lipoproteins (LP) including the determination of the content of apoproteins AI and B by quantitative "rocket" immunoelectrophoresis in 75 male patients aged 40 to 59 with normal body mass, with types I and II diabetes mellitus, in the state of compensation of carbohydrate metabolism, with and without signs of coronary heart disease. Sixty healthy men were controls. It was shown that in diabetic (types I and II) patients with CHD changes in LP spectrum values were similar to those in CHD patients without diabetes. In patients with type I diabetes without clinical signs of CHD, LP spectrum values including the content of apo-AI, apo-B and the ratio of apoB/apo-AI did not differ from those of the controls. Changes in LP-containing apo-AI expressed not only in the reduction of the total content of CH-HDIP but also in change of the composition of HDLP particles, were found in diabetic (type II) patients without clinical signs of CHD.